An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization

Background: Endometrial cancer (EC) is the most common gynecologic tumor and the world’s fourth most common cancer in women. Most patients respond to first-line treatments and have a low risk of recurrence, but refractory patients, and those with metastatic cancer at diagnosis, remain with no treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Torricelli, Federica, Sauta, Elisabetta, Manicardi, Veronica, Mandato, Vincenzo Dario, Palicelli, Andrea, Ciarrocchi, Alessia, Manzotti, Gloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001006/
https://www.ncbi.nlm.nih.gov/pubmed/36899930
http://dx.doi.org/10.3390/cells12050794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001006/
https://www.ncbi.nlm.nih.gov/pubmed/36899930
http://dx.doi.org/10.3390/cells12050794

Ejemplares similares